Skip to main navigation
Immuneering Corporation
  • Our Story
    • Overview
    • Leadership
    • Team
    • Board of Directors
    • Scientific Advisory Board
    • In the News
  • Our Science
    • Platform
    • Publications
  • Our Pipeline
    • Pipeline
    • Partnerships
  • Patients
    • Overview
    • Disease Focus
    • Clinical Trials
  • Investors
    • Overview
    • News & Events
      • Press Releases
      • Events & Presentations
      • In the News
    • Financial Information
      • SEC Filings
      • Annual Reports
      • Quarterly Reports
    • Stock Information
      • Stock Quote & Chart
      • Analyst Coverage
    • Governance
      • Documents & Charters
      • Board of Directors
      • Leadership
      • Committee Composition
      • Environmental, Social, and Governance (ESG)
    • Resources
      • FAQs
      • Email Alerts
      • Contact IR
      • RSS Feeds
  • Careers
    • Overview
    • Open Positions
    • Overview
    • News & Events
      • Press Releases
      • Events & Presentations
      • In the News
    • Financial Information
      • SEC Filings
      • Annual Reports
      • Quarterly Reports
    • Stock Information
      • Stock Quote & Chart
      • Analyst Coverage
    • Governance
      • Documents & Charters
      • Board of Directors
      • Leadership
      • Committee Composition
      • Environmental, Social, and Governance (ESG)
    • IR Resources
      • FAQs
      • Email Alerts
      • Contact IR
      • RSS Feeds

Quarterly Reports

Show all

2026

Q1

  • Earnings Release
  • Form 10-Q 748.7 KB

2025

Q4

  • Earnings Release
  • Form 10-K 3.9 MB

Q3

  • Earnings Release
  • Form 10-Q 1.1 MB

Q2

  • Earnings Release
  • Form 10-Q 1.2 MB

Q1

  • Earnings Release
  • Form 10-Q 871.7 KB

2024

Q4

  • Earnings Release
  • Form 10-K 6.6 MB

Q3

  • Earnings Release
  • Form 10-Q 936.6 KB

Q2

  • Earnings Release
  • Form 10-Q 725 KB

Q1

  • Earnings Release
  • Form 10-Q 891 KB

2023

Q4

  • Earnings Release
  • Form 10-K

Q3

  • Earnings Release
  • Form 10-Q

Q2

  • Earnings Release
  • Form 10-Q

Q1

  • Earnings Release
  • Form 10-Q

2022

Q4

  • Earnings Release
  • Form 10-K

Q3

  • Earnings Release
  • Form 10-Q

Q2

  • Earnings Release
  • Form 10-Q

Q1

  • Earnings Release
  • Form 10-Q

2021

Q4

  • Earnings Release
  • Form 10-K

Q3

  • Earnings Release
  • Form 10-Q

Q2

  • Earnings Release
  • Form 10-Q
 
Immuneering Corporation corporate site

© Immuneering Corporation 2026
All Rights Reserved.

Contact

info@immuneering.com

Boston
245 Main St, 2nd Floor
Cambridge, MA 02142

Media / Investor Inquiries:
ir@immuneering.com

 

 

New York
667 Madison Ave
New York, NY 10065

Partnering Inquiries:
ebrakewood@immuneering.com

 

 

San Diego
10864 Thornmint Road
San Diego, CA 92127

Clinical Trial Inquiries:
clinicaltrials@immuneering.com

Follow Us
  • Linkedin
  • Twitter
Legal
  • Terms of Use
  • Privacy Policy
MENU
  • Our Story
    • Overview
    • Leadership
    • Team
    • Board of Directors
    • Scientific Advisory Board
    • In the News
  • Our Science
    • Platform
    • Publications
  • Our Pipeline
    • Pipeline
    • Partnerships
  • Patients
    • Overview
    • Disease Focus
    • Clinical Trials
  • Investors
    • Overview
    • News & Events
      • Press Releases
      • Events & Presentations
      • In the News
    • Financial Information
      • SEC Filings
      • Annual Reports
      • Quarterly Reports
    • Stock Information
      • Stock Quote & Chart
      • Analyst Coverage
    • Governance
      • Documents & Charters
      • Board of Directors
      • Leadership
      • Committee Composition
      • Environmental, Social, and Governance (ESG)
    • Resources
      • FAQs
      • Email Alerts
      • Contact IR
      • RSS Feeds
  • Careers
    • Overview
    • Open Positions